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Abstract
Iron oxide-based nanomagnets have attracted a great deal of
attention in nanomedicine over the past decade. Down to the
nanoscale, superparamagnetic iron oxide nanoparticles can
only be magnetized in the presence of an external magnetic
field, which makes them capable of forming stable colloids in
a physio-biological medium. Their superparamagnetic prop-
erty, together with other intrinsic properties, such as low
cytotoxicity, colloidal stability, and bioactive molecule con-
jugation capability, makes such nanomagnets ideal in both
in-vitro and in-vivo biomedical applications. In this review, a
chemical, physical, and biological synthetic approach to
prepare iron oxide-based nanomagnetswith different physico-
chemical properties was illustrated and compared. The
growing interest in iron oxide-based nanomagnets with
multifunctionalities was explored in cancer diagnostics and
treatment, focusing on their combined roles in a magnetic
resonance contrast agent, hyperthermia, and magnetic force
assisted drug delivery. Iron oxides as magnetic carriers in
gene therapy were reviewed with a focus on the sophisticated
design and construction of magnetic vectors. Finally, the iron
oxide-based nanomagnet also represents a very promising
tool in particle/cell interfacing in controlling cellular func-
tionalities, such as adhesion, proliferation, differentiation,
and cell patterning, in stem cell therapy and tissue engineer-
ing applications.
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1A brief history of iron oxide research
I
ron oxides are a collective term for oxides, hydro-
xides, and oxy-hydroxides composed of Fe(II) and/or
Fe(III) cations and O
2 and/or OH
 anions. The
understanding and applications of iron oxide as an
important mineral originated thousands of years ago
(1). In ancient China, magnetic compass was invented
and used by many navigators to determine the direction
of north pole of Earth. The term ‘magnetite’ originated
from the district of Magnesia in Asia Minor, where plenty
of such mineral exist.
Nowadays, there is widespread research on iron oxides
across many scientific disciplines, including both funda-
mental research and applications, such as mineralogy,
biology, geology, chemistry, and medicine, as shown in
Fig. 1. In modern mineralogy, for instance, the crystal
structures, properties, and formation of iron oxide
nanoparticles are well characterized. In industrial chem-
istry technology, iron oxide applications in painting
pigments, catalysts, and magnetic recording are explored
and refined. Interestingly, bio-mineralization of crystal-
line magnetite in Magnetobactericum sp. attracted en-
ormous attention in nanomedicine due to its narrow size
distribution and magnetic properties (2). Such multi-
disciplinary research has led to a very fruitful and much
deeper understanding of iron oxides and many potential
applications have been proposed and studied, from which
this work originated and benefited. In this review, we
focus on the synthesis of iron oxide nanoparticle-
based multifunctional nanomagnets in nanomedicine, to
illustrate how the advanced nano-device benefits the
development of nanomedicine and how fundamental
biomedical research with nanoparticles influences nano-
technology.
Synthesis of nanomagnets
Chemical-based synthesis
Coprecipitation
Alkaline coprecipitation of Fe(III) and Fe(II) salts in
aqueous media is the most universally adopted synthetic
approach to produce iron oxide nanoparticles, due to its
versatility, relatively low budget, feasibility to scale up,
and the hydrophilic surface character of the resultants. It
is possible to fabricate pure-phase magnetite by control-
ling the reaction factors, resulting in controlled particle
size and morphology (3). Kang et al. (4) reported the
preparation of monodispersed magnetite nanoparticles
with an average size of 10 nm in aqueous solution. The
reaction of magnetite in aqueous media can be written as
follows:
2Fe
3Fe
28OH
 0 Fe3O44H2O (1)
In general, the coprecipitation method was established
by ‘trial and error’ approaches in the past decades; only a
few research groups reported the systematic study of the
chemistry of the reaction system. Babes et al. (5)
performed a comprehensive quantitative analysis of
different reaction parameters, including composition
of the alkaline media, pH, temperature, concentration of
iron species, etc. Kim et al. (6, 7) took a step forward to
perform a thermodynamic modeling study of the reaction
equilibrium involved in the coprecipitation of magnetite
in aqueous solution, with theoretical considerations of
changes in free energy and redox potential of the iron
species . The thermodynamic modeling diagram is shown
in Fig. 2.
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magnetite by oxidation of Fe(II) in solution, as the
reaction can be written as follows:
3Fe
24H2O 0 Fe3O46H
6H2 (2)
Fe
2O2OH
 0 Fe3O4H
 (3)
It is essential to adjust the stoichiometric ratio of Fe(II)/
2Fe(III) at the initial stage because it is quite difficult to
control the oxidation kinetics of Fe(II) afterward. Oxygen
also plays an important role in the formation of single-
phase magnetite; thus, bubbling the nitrogen gas directly
into the media prior to reaction is efficient enough for
removal of oxygen. Kang et al. deliberately transformed
magnetite nanoparticles into maghemite by aeration
(oxidation) at 1008C, which can be written as follows (4):
4Fe3O4O2 0 6gFe2O3 (4)
Interestingly, the morphologies of the particle could be
tuned by different types of alkaline media: Babes et al.
reported the preparation of well-faceted particles using
the weak alkaline of tetramethylammonium hydroxide
(TMAOH) (5); while Kang et al. prepared spherical
magnetite particles using the strong alkaline of ammoni-
um hydroxide or sodium hydroxide (4). Babes et al.
demonstrated that the formation of spherical particles is
because the nucleation rate per unit area is isotopic at the
interface of the iron oxides and reactant solution (5).
Therefore, particle shape can be tuned by controlling the
rate of nucleation per unit area with the alkaline ionic
strength.
Better size, morphology, and colloidal dispersion was
realized based on a modified coprecipitation synthesis, by
applying the principle of nucleation in highly constrained
domains. Kim et al. (8) prepared spherical-shaped super-
paramagnetic iron oxide nanoparticles (SPIONs) with an
average size of 7.2 nm within a polymeric starch matrix,
in contrast with uncoated SPIONs with an average size of
12 nm. Lin et al. reported completely separated dextran-
coated magnetic nanoparticles by chemical cleavage of
the dextran structure with diamine molecules, resulting in
monodispersed SPIONs with an average diameter of 4.5
nm in aqueous media.(3)
Microemulsion/nanoemulsion (nE)
Microemulsion (mE) is defined as the thermodynamically
stable isotropic dispersion of two immiscible liquids,
stabilized by a monolayer of surfactant at the interface
of the two liquids. In the water/oil (w/o) mE (or referred
to as inverse mE) system, small aqueous nanodroplets
are dispersed in the organic phase, and vice versa. The
nano-sized water droplets containing iron ions and the
alkaline source, act as confined reactors that undergo
rapid coalescence and mixing to allow the chemical
reaction. Attributed to the confinement of particles
nucleation and growth within nano-sized droplets, the
mE approach is capable of providing good control over
particle size and size distribution. Santra et al. (9)
performed the parametric study on the effect of different
surfactants and alkalines in the mE reaction system and
reported synthesis of SPIONs as small as 12 nm with
very narrow size distribution. They had speculated that
the absorption of the surfactant onto the particle
surfaces was based on weak hydrogen bonding between
the terminal hydroxyl group of the non-ionic surfactant
and oxygen atoms on iron oxide surfaces. However,
the hydrophobic tail of the surfactant often causes
interconnection and aggregation of particles in an
ordered fashion due to hydrophobic interaction with
each other (9).
The mE approach has been explored as a polymeriza-
tion process for coating polymer or silica onto
pre-synthesized iron oxide cores to produce magnetic
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Fig. 1. The multidisciplinary nature of modern research in iron oxides, with a focus on the strong inﬂuential effect between
medical applications and material engineering.
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(page number not for citation purpose)spheres with tunable shell thickness. Dresco et al.
(10) demonstrated the fabrication process of magnetic
hydrogel particles consisting of iron oxide cores and
poly(methacrylic acid)-co-poly(2-hydroxyethyl methacry-
late) (PMA-PHEMA) copolymer shells, with an average
size of 80320 nm, by a two-stage mE method. Yi et al.
(11) reported the synthesis of mesoporous silica-coated
SPIONs by a single-step reverse mE process, taking
advantage of the small size and spherical nature of
nanodroplets to produce magnetic silica spheres with
tunable silica shell thickness of 1.830 nm.
Thermal decomposition
Inspired by the advanced fabrication of semiconductor
and metallic nanocrystals (12), the decomposition of
organometallic complexes at high temperature was
adopted to fabricate high quality and monodispersed
metal oxide nanocrystals. Rockenberger et al. (13)
reported fabrication of near-monodispersed g-Fe2O3
nanocrystals by thermal decomposition of iron cupferron
complex (FeCup3) in octylamine. Hyeon et al. reported
the synthesis of highly crystalline and monodispersed g-
Fe2O3 nanoparticles with one-nanometer-scale size con-
trol from 4 to 16 nm, by oxidative decomposition of iron
pentacarbonyl (Fe(CO)5) in the presence of oleic acid
(OA) as a capping agent and trimethylamine oxide
(TMAO) as an oxidative agent in octyl ether as a non-
coordinating solvent without size selection process (14,
15). Sun and Zeng (16) succeeded in producing mono-
dispersed magnetite nanocrystals with a controllable size,
from 4 to 16 nm, by thermolysis of iron acetylacetonate
(Fe(acac)3) in the presence of OA, oleylamine, and
alcohol in phenyl ether. Jana et al. (17) reported the
synthesis of high-quality magnetite nanocrystals, from a
few nanometers up to 50 nm, by adjusting the concentra-
tion of the stabilizing ligands and iron precursors during
the reaction.
Of all the iron-containing organometallic complexes,
both ferric and ferrous fatty acid complexes are the most
preferred iron precursors because of their low prepara-
tion cost, low toxicity, and feasibility for mass production
(1820). The iron carboxylate can be prepared by
neutralization reaction with Fe(III) salts and sodium
carboxylate (19) or dissolution of iron oxides or hydro-
xides in carboxylic acid (18). Hyeon et al. reported an
economical and environmentally friendly synthetic ap-
proach to prepare size-tunable g-Fe2O3 nanocrystals up
to 22 nm in non-coordinating solvent by adjusting the
reaction time and temperature, as shown in Fig. 3.
Attempts at thermolysis of organometallic complexes
in the water miscible solvent at high temperature were
made, although scarification of particles occurred. Li
et al. (21, 22) chose 2-pyrrrolidone as both passivating
ligands and solvents, owing to its ability to form a strong
coordination bond with the surface of metallic oxides,
relatively high boiling point, and miscibility with water.
The same group had improved the particle dispersion and
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Fig. 2. Thermodynamic modeling diagram showing: (a) the
pH-pE predominance diagram of the FeClH2O system at
258C; (b) the distribution of the fraction of [Fe
x]/[Fe
2
Fe
3] vs. pH calculated at 258C for 0.3 M Fe
2 and 1 M
HCl solution: E0 V; and (c) E0.4 V. Reprinted from
Srcripta Mater, Vol. 44, Kim DK et al., Superparamagnetic
iron oxide nanoparticles for bio-medical applications, 1714,
Copyright (2001), with permission from Elsevier. Reprinted
from Chem Mater, Vol. 15, Kim DK et al., Starch-coated
superparamagnetic nanoparticles as MR contrast agents, 4350,
Copyright (2003), with permission from ACS Publications.
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poly(ethylene glycol) (PEG) (23).
Physical-based synthesis
Lithography and sputtering
The definition of ‘top-down approach’ in nanomaterials
synthesis is to reduce the starting block materials to a
desirable nanoscale by controlled etching, elimination,
and layering of the materials, which mainly involves
lithography (24). Despite being a well-developed method
in semiconductor microchip fabrication, lithography
techniques are far from satisfactory in the fabrication
of nanomaterials. Firstly, such a top-down approach
often results in surface crystallographic defect of the
prepared nano-patterns, which may seriously affect their
physico-chemical properties. Secondly, lithography has its
own dimensional limitations because of the limited
wavelengths of the ‘light source.’ A nano-feature less
than 100 nm is difficult to produce by conventional
photolithography, and nano-patterns smaller than 10 nm
cannot be produced even by electron beam lithography.
Fig. 4 illustrates a typical step-wise fabrication of a
magnetic disk by photolithography and sputtering tech-
niques (25, 26). Firstly, aphotoresist layer with athickness
of 1 mm was spin-coated onto a silicon wafer, followed by
placement of a mask (1 mm diameter circular dot-arrayed
patterns) in contact with the pre-packed photoresist layer.
Secondly, UV light was illuminated though the mask for
development, and the unexposed photoresist layer was
dissolved and removed by the addition of an organic
solvent. Finally, magnetron sputtering was used to deposit
5 nm underlayered gold, followed by 60 nm of permalloy
(Fe20Ni80), and topped with another 5 nm of gold layer.
The disks were released from the wafer by the lift-off
process via acetone wash. This approach allows low-cost
production of uniformly sized microdisks (MDs) with
magnetic spin state in remanence (26).
Biological-based synthesis
Magnetosome in magnetotactic bacteria
Magnetotactic bacteria (MTB) and magnetosomes have
attracted much attention across many disciplines in the
past decade and have been intensively studied as a model
system in bio-mineralization mechanism and evolution-
ary bacteriology (27). Magnetosome, intracellular mag-
netite (Fe3O4) or greigite (Fe3S4) nanocrystals surrounded
by lipid membranes in MTB are of particular interest in
bio-nanomedicine, because of their strain-dependent
shape and size, intrinsic high saturation magnetization,
inherent biocompatibility, and perfect dispersion in
biological medium (24). Interestingly, within certain
bacteria strains, the particle morphology and size is
Fig. 3. TEM images and HR-TEM of iron oxide nanocrys-
tals prepared from thermolysis of iron (III) oleate complexes
in non-coordinating solvent with average diameters of (a, f)
5 nm; (b, g) 9 nm; (c, h) 12 nm; (d, i) 16 nm; and (e, j) 22 nm,
respectively. Reprinted from Nat Mater, Vol. 3, Park J et al.,
Ultra-large-scale synthesis of monodisperse nanocrystals,
892, Copyright (2004), with permission from Nature Pub-
lishing Group.
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of the magnetosome membrane with the growing nano-
crystals facilitates crystal growth in a certain direction,
while crystal growth in other directions is retarded,
resulting in cuboctahedral, hexagonal, or bullet-shaped
magnetosomes (27, 28).
The bio-mineralization process of magnetosomes has
been intensively studied and reported by several groups.
To generalize the magnetosomes formation procedures,
iron ions are firstly transported into the cell via both
specific siderophores and/or non-specific mechanisms and
then actively deposited within the magnetosome mem-
brane to form a saturated iron ion solution, followed by
the redox reaction of iron within the magnetosome
membrane (24, 27). It is important to note that Fe(III)/
Fe(II) were strictly controlled at a stoichiometric molar
ratio of 2/1 to yield magnetite nanocrystals. Although
certain redox mechanisms areunknown, it iswell accepted
that the cellular uptake of Fe(III) was firstly reduced to
Fe(II) to be transported into magnetosome membrane
vesicles, followed by the redox process into hydrous
Fe(III) oxides. Afterward, one third of Fe(III) in hydrous
oxides was reduced to Fe(II) to form magnetite followed
by dehydration.
Recently, to overcome the magnetic softness problems
of magnetite magnetosomes in nanomedicine applica-
tions, an in-vivo cobalt-doping method has been intro-
duced to increase the coercive field that is needed to
reverse the magnetization without significant loss in
saturation magnetization of magnetosomes (29). Fig. 5
shows transmission electron microscopic images and
hysteresis loops of undoped and cobalt-doped magneto-
somes within three different MTB strains (Magnetospir-
illum gryphiswaldense MG, M. magnetotactricum MS1,
and M. magneticum AMB1). It is possible to expand this
method into other metal ions, such as titanium, copper,
and nickel, to improve significantly the biologically
controlled synthesis of magnetic particles with tunable
physico-chemical properties in vivo.
Nanomagnets in nanomedicine
When the particle size reduces to a certain size (a few
nanometers), the formation of a domain wall is not
favorable, hence the particle only contains a single
magnetic domain in which all atomic magnetic moments
align with each other. Even at ambient temperature, the
thermal energy is still comparable to the magnetic
anisotropy to change the direction of the magnetic
moment of each individual particle (1). The fundamental
Spin coating
Silicon wafer P
Development
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Master
Magnetron sputtering
Lift-off
Magetic micromisks
1 µm
60 nm
(a)
(c)
(e)
(b)
(d)
(f)
Fig. 4. The fabrication of microdisks (MDs) by optical lithography and magnetron sputtering. (a,b) The process starts with
photoresist spin coating on a silicon wafer; (c) a mask is placed in contact with the layer of pre-packed photoresist and
illuminated with UV light. (d) An organic solvent dissolves and removes unexposed photoresist. (e) Finally, magnetron
sputtering is used to deposit 5 nm underlayer gold, followed by 60 nm of permalloy, and topped with another 5 nm of gold layer.
(f) The disks are released from the wafer by lift-off process. Reprinted from Nat Mater, Vol. 9, Kim D-H et al., Biofunctionalized
magnetic-vortex microdiscs for targeted cancer-cell destruction, supplementary information P3. Copyright (2010), with
permission from Nature Publishing Group.
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superparamagnetism. In the absence of an external
magnetic field, the magnetic moment of each particle is
randomly oriented due to thermal fluctuation, resulting
in zero net magnetization; in the presence of an external
magnetic field, they tend to align with the field and
exhibit avery strong magnetization in the direction of the
external field, hence they can be targeted by an external
magnetic field in an on-off fashion.
Nanotoxicology
Safety issues of nanoparticles in any clinical applications
are a major concern. Although iron oxides are relatively
less toxic compared to other transition metal or semi-
conductor nanomaterials, concerns regarding toxicity still
remain in iron oxide-based nanomedicine, such as
magnetic resonance imaging (MRI) and magnetic force
drive drug/gene delivery. The term ‘non-invasive’ is
controversial, because originally it implied that ‘neither
surgical procedures nor scissions were involved,’ however,
recent studies have shown the possibilities of iron oxide
nanoparticles affecting normal cell functionalities, in-
stead of simply being carriers (30, 31). It has been widely
accepted that uncoated iron oxide nanoparticles elicit
massive cellular internalization associatedwith significant
cell death, however, iron oxide nanoparticles coated with
Fig. 5. Magnetization properties of doped and undoped magnetosomes from different bacterial strains. (ac) TEM micrographs,
hysteresis loops, and length histograms for M. gryphiswaldense MG (a), M. magnetotacticum MS1 (b), and M. magneticum
AMB1 (c). The TEM micrographs correspond to doped magnetosome chains unless otherwise indicated. Insets to (a) TEM
images showing undoped [MGFe] magnetosome chains (left inset) and a whole cell of [MGFe] (right inset). The hysteresis
loops were measured at 300 K. Closed squares, open triangles, and open circles indicate the magnetosomes corresponding to
[Fe], [FeCo], and [Co] growth conditions. The histograms indicate the length distribution of [Fe] (red) and [Co] (blue) particles.
The scale bars are 500 nm. Reprinted from Nat Nanotechnol, Vol. 3, Staniland S et al., Controlled cobalt doping of
magnetosome in vivo, 159. Copyright (2008), with permission from Nature Publishing Group.
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less cytotoxicity in a range of cell lines (32). Gupta (33)
demonstrated a dose-dependent reduction in cell adhe-
sion and viability of bare iron oxide nanoparticles, while
pullulan, lactoferrin, and ceruloplasmin (32) coated
nanoparticles showed no significant cell detachment or
morphology changes on human fibroblasts.
Although the mechanism of nanoparticle-mediated
cytotoxicity is not fully understood, it has been proposed
that it is attributed to the generation of reactive oxidative
species (ROS) and cellular internalization (30). Transition
metal or transition metal oxide nanoparticles can
generate ROS as catalysts in a Fenton-type reaction, in
which hydrogen peroxide is reduced by ferrous ions to
form extremely active hydroxyl-free radicals and lead to
biological damage within the diffusion range (30).
+
O

2 H2O2  !
Fe(II)=Fe(III) +
OHOH
O2 (5)
Studies of the intracellular destination of iron oxide
nanoparticles are particularly important in determining
the cytotoxicity of such nanomaterials and designing
effective and bio-safe nano-devices for biomedical appli-
cations. Most of the work has focused on receptor-
mediated internalization and the endocytic pathway
of such nanostructures, including the effect of the
physico-chemical properties of nanoparticles, i.e. size,
shape, chemical composition, surface-to-volume ratio,
and surface charges, on the cellular response of different
cells (34). It has been established that receptor-mediated
internalization strongly depends on the size of the
particles (31). Both clathrin- and caveolae-mediated
endocytosis has been reported, however, controversial
results on the effect of particle size and surface coating on
the endocytosis pathway has also been reported (31).
Nanomagnets in cancer diagnostics and therapy
The excellent features of nanomagnets are their multi-
functional properties and the potential combination of
neoplastic diagnostics and therapeutics (35). In target-
oriented drug delivery systems (DDS), more sophisti-
cated designs are required to achieve targeted delivery by
both physical and biochemical means and controlled
release if necessary. Fig. 6 illustrates the various ap-
proaches of cancer-specific DDSs. Drugs such as protein
toxins are transported to intracellular sites via receptor-
mediated endocytosis (shown in the center). On the left,
immunomodulators (e.g. cytokines) are coupled to a
tumor-specific ligand (e.g. antibodies, folic acid) and
localized on the cell surface to elicit an immune response.
On the right, prodrug-activating enzymes are concen-
trated on the cell surface and can subsequently convert
the prodrug into an active drug (36). Stimuli-activated
drug release, once combined with the nanomagnet, is of
particular interest in anti-cancer drug delivery. Qin et al.
(37) recently developed a system consisting of hydro-
phobic nanocrystals and amphiphilic thermosensitive
copolymers, which exhibit a sharp and reversible low
critical solution temperature. An MRI technique with
tumor-specific nanomagnets as contrast agents was used
to locate the diseased site prior to magnetic fluid
hyperthermia (MFH) treatment, which is also mediated
by nanomagnets and triggered by an external AC
magnetic field or active drug release from the nano-
magnet carriers via an external stimuli, such as pH or
temperature change, and enzymatic cleavage (38). Jian et
al. tested the dual functionalities of Pluronic-stabilized
magnetic particles as doxorubicin and/or paclitaxel
carriers and MR contrast agent to show the high clinical
significance of the multifunctional magnetic carrier in
cancer treatment (35). Similarly, Jarzyna et al. (39)
developed oil-in-water emulsions encapsulating magnetite
nanoparticle cores as a dual-functional platform, in
which magnetite particles act as MR probes and hydro-
phobic drugs can be loaded and released in the soybean
oil core. Julian-Lopez et al. (40) reported facile fabrica-
tion of the hybrid silicaspinel iron oxide composite with
Target antigen
Drug cargo
Target molecules
Immunomodulator
Prodrug
Active drug
Enzyme
Cell surface
Fig. 6. Schematic presentation of targeted delivery of therapeutic proteins and peptides to antigen-positive tumor cells or tumor
vasculature. Reprinted from AAPS J, Vol. 8, Lu Y et al., Issues related to targeted delivery of proteins and peptides, E476,
Copyright (2006), with permission from SpringerLink.
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ous matrix enabling the transport of therapeutic mole-
cules in vivo. Despite potential toxicity, metallic iron
nanoparticles coated with carboxyl-terminated PEG with
a diameter of 10 nm have also been reported to exert local
hyperthermia under an oscillating magnetic field and
have a stronger T2 shortening effect as another possible
multifunctional nano-platform (41). Both the outer coat-
ing substances and the interaction between the polymeric
coating and particle surface often significantly influence
the characteristics of the resulting MR probes. Jain et al.
(42) reported that the Pluronic F127 stabilized magnetic
particles sustained and enhanced accumulation in
tumor tissues compared with commercial Feridex IV.
Muhammed et al. also reported the use of Pluronic F127
as a phase transfer agent for hydrophobic magnetic
nanocrystals prepared by thermolysis; and Pluronic
F127 modified nanoparticles had shown a significant
T2 shortening effect as MR contrast agents and con-
trolled released behavior of hydrophobic anti-cancer
drugs (43, 44). However, the translation of nanomagnets
from laboratory into clinical setting remains complicated.
The major issue regarding magnetic force assisted
DDS and MFH is the relatively high concentration of
magnetic carriers required for sufficient accumulation of
anti-cancer drugs (magnetic force-based DDS) or induc-
tion of heat-induced apoptosis, which may result in
undesirable side effects and the requirement for a strong
external magnetic field generated by coil/power supply
systems (38, 45).
Sufficient delivery of local hyperthermia and anti-
cancer drugs is strongly dependent on the cellular
internalization competence of magnetic nanoparticles.
Active cancer targeting can be achieved by further
conjugations with particular targeting ligand on nano-
particles, as shown in Table 1. Numerous potential
malignancy targeting ligands have been identified as
considerable improvements have been made in cancer
biology in the past decade, among which the Arginine
GlycineAspartic acid (RGD) peptide sequence is of
particular concern in active cancer targeting, attributed
to the abundance of integrin receptors in various
carcinomas. Fig. 7 shows the binding effects of magnetic
nanoparticles to cancer cell via RGD-integrin interaction,
which leads to receptor-mediated endocytosis of RGD-
modified magnetic nanoparticles (46, 47). Folic acid, also
called vitamin B9, has also been widely used to target
different types of cancer; Fig. 8 shows confocal micro-
scope images of the cellular uptake of magnetic nano-
particles functionalized with folic acid (48).
Nanomagnets in stem cell therapy
Stem cells are characterized by their self-renewal cap-
ability via mitotic cell division and differentiation into
different specialized cell types. Transplantation of stem
cells is the administration of stem cells in vivo to
regenerate, repair, or restore the functionality of various
organs or tissues. It has attracted enormous attention for
the treatment of various diseases, such as leukemia,
neural degenerative diseases, cancer, spinal cord injuries,
Table 1. Active cancer-targeting strategies of magnetic nanoparticle biomedical applications
Active ligand Surface receptors Cancer cells Applications
RGD peptide Integrin aVb3 Breast carcinomas siRNA delivery (47)
Glioblastoma Brain tumor diagnosis by MRI and
near-infrared fluorescent (NIRF)
imaging (79)
Activated platelets Thrombus visualization by MRI (80)
CTX (chlorotoxin) MMP-2 (matrix
metalloproteinase-2)
Gliomas medulloblastomas Brain tumor diagnosis by MRI
(81, 82)
Herceptin HER2 (human epidermal
growth factor receptor 2)
Breast cancer Platin delivery (83, 84)
Breast cancer diagnosis by MRI (7)
Localized hyperthermia (85)
Anti-TfR (transferrin
receptor) MAb
TfR (transferrin receptor) Hematopoietic and neural
progenitor cells
MR tracking of cell differentiation and
migration (86, 87)
Gliosarcomas MR detection of gene expression (88)
Tf (transferrin) Cervical cancer Gene delivery (89)
LHRH (luteinizing
hormone-releasing
hormone)
LHRHR (luteinizing
hormone-releasing hormone
receptor)
Breast cancer
Ovarian cancer
Targeted Fe-induced apoptosis in
cancer treatment (90)
Breast tumor and metastases
detection by MRI (91, 92)
FA (folic acid) FAR (folic acid receptor) Breast cancer
Epithelial carcinomas
Early diagnosis by MRI (93, 94)
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the fundamental and practical aspects of stem cell
transplantation, thus non-invasive tracking of final
destination and differentiation of administered stem cells
is important in stem cell research. Among the existing cell
labeling and monitoring techniques, such as with cell
membrane dyes, fluorescent dyes, and positron emission
tomography (PET) scanning, MRI has been focused as a
potential technique for tracking the transplanted stem
cells due to its non-invasive and real-time cellular
tracking abilities with high spatial resolution (49). It
has been proved that the magnetic labeling of human
mesenchymal stem cells (hMSCs) and CD34
 hemato-
poietic stem cells with iron oxide nanoparticles allows
tracking of labeled cells by MRI at single cellular level
(50).
The prerequisite for achieving the MR signal of
administered objective cells in vivo is loading sufficient
contrast agents without influencing cell viability, prolif-
eration, and functionalities (including differentiation
ability). The effective and selective magnetic labeling of
stem cells can be achieved by sophisticated surface
conjugation on nanomagnets. Dunning et al. (51) re-
ported the successful magnetic labeling and in-vivo MR
tracking of Schwann cells and olfactory ensheathing cells
(OEC) after transplantation into the central nervous
system (CNS). Arab et al. (52) reported an evaluation
of the loading efficiency, cell toxicity, capability of
differentiation, and phenotypic changes of hMSCs and
CD34
 hematopoietic stem cells, after labeling with
ferumoxides complexed with protamine sulfate and con-
jugated with a polycationic peptide for transfection.
Lewin et al. (53) demonstrated the effective endocytosis
of human immunodeficiency virus (HIV) derived mem-
brane translocation signal Tat peptide-linked iron oxide
nanoparticles into CD34
 hematopoietic and neural
progenitor cells. Matuszewski et al. also studied the effect
of lipophilic transfection medium and particle size on
labelling efficiency of cells, which shed some light on
rational design of nanomagnets (49). Magnetic labeling of
stem cells not only enables non-invasive tracking and
quantification of cells, but also facilitates the targeted
deposition of stem cells into certain targeted areas in vivo
by magnetic resonance fluoroscopy. Alexander et al. (54)
demonstrated the precisely guided administration of
magnetic labeled MSCs into the area between the
myocardial infarcted and normal tissue by a clinical
magnetic resonance fluoroscopy procedure.
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Fig. 7. Schematic illustration of receptor-mediated binding event of magnetic particles and cell. cRGD peptide was conjugated
to the nanomagnet through a protective coating layer (e.g. dextran or PEG); cRGD motif recognize the RGD binding domain of
the integrin avb3 receptors that overexpressed on tumor cells.
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Gene therapy involves the insertion of genetic materials,
including plasmid DNA, small interference RNA
(siRNA), double-stranded DNA (dsDNA), messenger
RNA (mRNA), and oligonucleotides (ODNs), into target
cells or tissues to express heterogeneous gene products,
knockdown mutated deleterious genes, and replace with
functional ones. Although gene therapy has shown
promising results for the treatment of hereditary diseases,
such as cystic fibrosis, thalassemia, Parkinson’s disease,
Huntington’s disease, inherited color blindness, etc.,
development of effective non-viral vectors remains one
of the biggest challenges to replace potentially toxic and
immunogenic viral vectors. For this reason, magnetofec-
tion was established to take advantage of both the
biochemical (cationic lipids or polymers) and physical
means (magnetic forces) for accelerated nucleic acid (NA)
delivery to the target cells (55).
Li et al. (56) reported that transfection efficiency of
PEI/DNA polyplexes, which are covalently linked to
dextran-modified magnetic beads (200 nm), shows 35-
to 85-fold higher values under magnetic field. Similarly,
Xenariou et al. (57) demonstrated reporter gene expres-
sion of Lipofectamine 2000/pDNA lipoplex increase 300-
fold under a magnetic field, when complexed with
TransMAG
PEI (consisting of iron oxide cores and PEI
shell) at suboptimal pDNA concentrations. Mykhaylyk
et al. (58) recently described self-assembly of DNA and
cationic lipid or polymer-associated magnetic nanoparti-
cles for in-vitro magnetic force-assisted transfection of
both adherent and suspended cells.
Huth et al. (59) systematically investigated the me-
chanisms of magentofection of PEI-based magnetic
nanoparticles. The cellular uptake pattern of PEI-mod-
ified magnetic nanoparticles is virtually the same as
polyplexes via the endocytic pathway. Fig. 9 illustrates
the mechanisms of the proton sponge effect, in which
genetic materials are released from cationic lipid- or
polymer-coated magnetic particles in acidic endosomes.
Cationic magnetic particles are endocytosed in the tight-
fitting vesicles, attributed to electrostatic interaction
between negatively charged cell membrane and cationic
magnetic particles. Once the particles are endocytosed in
the endosomal environment, the unsaturated amino
groups (e.g. PEI coating) sequester the pumped-in-
protons by the ATPase residing on the endosomal
membrane, which leads to retention of Cl
 ions and
water molecules in the endosome. As the water retention
builds up, the endosomes swell and burst, resulting in the
release of genetic material and magnetic particles into the
cytoplasm (60). It has been reported that the accelerated
sedimentation of DNA is the main driving force for
Fig. 8. Confocal microscopy images of KB cells treated with FA functionalized SPIONs for 1 h at 378C, 5% CO2. Nuclei was
stained with DAPI to give blue ﬂuorescence, SPIONs were conjugated with 6-TAMRA dye to give red ﬂuorescence. The scale
bars are 40 mm (A) Negative control KB cells without any treatment; KB cells with (B) FAR blocked; (C) with G5-Ac(102)-
FA(5)-6T3; (D) with FA-SPIONs at 50 nM; and (E) 100 nM. Reprinted from ACS Nano, Vol. 2, Landmark KJ, Synthesis,
characterization, and in vivo testing of superparamagnetic iron oxide nanoparticles targeted using folic acid-conjugated
dendrimers, 778. Copyright (2008), with permission from ACS Publishing Group.
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with magnetic vectors (59). Namiki et al. (61) reported
effective magnetic field-guided siRNA delivery with
LipoMag†, which consists of an OA-coated iron oxide
core and cationic lipid shells, in mice gastric tumor
models. Cohorny et al. (62) reported polylactide-induced
small clusters of OA-coated magnetic nanoparticles and
subsequent PEI/oleate ion pair by emulsion-evaporation
method.
Subcellular targeting with magnetic gene carriers
represents another avenue for gene therapy. The discovery
of HIV Tat protein transduction domains (PTD) and
nucleus localization signals (NLS) has opened up a new
approach to using cell-penetrating peptides (CPPs) to
direct in-vitro and in-vivo delivery of therapeutic agents
on target sites (63, 64). Lewin et al. (53) labeled CD34

neural progenitor cells with Tat peptide-derivative mag-
netic NPs for in-vivo MR tracking and recovery of
progenitor cells. During the past decade, tremendous
progress has been made in protein transduction study,
various CPPs and peptidomimetics have been indentified
for subcellular and specific delivery of proteins, DNA,
drugs, and imaging probes; however, the internalization
mechanism of CPPs are not well investigated (65). A
common feature of such CPPs is the high incidence of
basic amino acid residues, such as Arg and Lys (Fig. 10);
it can be considered that the guanidine groups of Arg is a
critical component for the biological activity of CPPs,
and hydrogen bonding between highly basic Arg (or Lys)
and phospholipids bi-layer may be involved in transduc-
tion into cells (66, 67). Fig. 10 shows a list of molecular
structures and amino acid sequences of CPPs from
different origins.
Nanomagnets in tissue engineering
In the early 1990s, Langer and Vacanti (68) first gave the
definition of tissue engineering: ‘an interdisciplinary field
that applies the principles of engineering and life science
toward the development of biological substitute that
restore, maintain, or improve tissue function or a whole
organ.’ Significant achievements are reported in the
construction of bio-functional tissues inside the scaffold
matrices in vitro via a combination of the development in
biological active scaffold, tissue-culturing techniques (e.g.
bio-reactors), and in-depth understanding of cell biology,
including the physiology of the tissue-scaffold microen-
vironment and the ability to induce of cellular function-
ality of some bioactive molecules.
Several researches have demonstrated the feasibility of
constructing 2D or 3D tissue integrities byorientating the
cells under an external magnetic field. Ito et al. reported
the construction of monotypic and heterotypic cell
multilayer sheets of liver endothelial cells, skeletal muscle
cells, and mesenchymal stem cells by magnetic-induced
forces (6971). The same group also demonstrated
increased cell-seeding density via magnetic forces, result-
ing in the formation of bone-like tissues within 3D
scaffold matrices (72, 73). Recently, micro-patterning of
Fig. 9. Schematic illustration of the proton sponge effect leading to endosomal or lysosomal burst and release of the cationic
magnetic particles into the cytoplasm. Reprinted from Nat Mater, Vol. 8, Nel AE, Understanding biophysiochemical
interactions at the nano-bio interface, 552. Copyright (2009), with permission from Nature Publishing Group.
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cell-adhesive surface in vitro has been achieved by
selectively labeling the target cells with peptide-modified
magnetite liposome with a computer-aided precise posi-
tioning of the steel plate under an external magnetic field
(47). Such magnetic force-based micro-patterning techni-
ques show promising results in skin regeneration (74).
Advanced magnetic actuation of cells
Remote manipulation of cells and cellular components
in vitro and in vivo provides an important tool to
understanding the cell functional and cellular signaling
pathway. In the past few years, significant efforts have
been made in magnetic force targeting for the mechano-
sensitive ion channels of the cells in vitro, the ligand
receptor binding, receptors activation and clustering,
downstream signaling pathway, and subsequent pheno-
type changes have been investigated with a variety of cell
lineages (7577). Compared to other remote control
techniques, such as optical tweezers, the magnetic
manipulation via nanomagnets allows ‘action at dis-
tance’ while maintaining the precise localization of
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such distance between the external magnetic field and
the nanomagnet represents the possibility of overcoming
interfering with the tissue structures by remote cell
control in vivo (78).
Recently, a top-down approach by photolithography
and etching has been reported to fabricate 2D magnetic
MDs with a spin-vortex ground state. Such ferromagnetic
MDs have two advantages in nanomedicine applications:
zero remanance and the ability to respond external
frequency. Kim et al. (25) reported the induced apoptosis
of several cancer cells by the mechanical forces induced by
the spin-vortex at very low frequency (tens of Hz) for a
short time (10 min). Fig. 11 schematically shows that the
antibody functionalized magnetic MDs selectively bind to
the cancer cells, followed by transduction of the mechan-
ical force to the phospholipids membrane, causing
membrane destruction and eventually DNA damage (25).
Future perspective and outlook
In the past decade, nanomedicine in nanotechnology has
been rapidly growing as an active research field because
of its adaptable application in targeting, drug delivery,
diagnosis, and treatment of various diseases and ailments.
In this paper, several advanced fabrication techniques for
the synthesis of multifunctional nanomagnets with novel
physico-chemical properties have been reviewed, together
with their promising applications in nanomedicine, such
as cancer treatments, stem cell tracking and therapy, gene
therapy, and tissue engineering. The challenge remains to
translate nanomagnets from the laboratory into clinical
applications. One of the major obstacles in magnetic
drug/gene delivery is that the currently available magnets
are not strong enough to magnetize the magnetic
nanoparticles to counterbalance the blood flow for
effective accumulation of nanomagnets at the target
site. The development of high-quality magnetic nanopar-
ticles with a strong magnetization and powerful external
magnetic field is equally essential in potential magnetic
drug/gene delivery applications. Moreover, iron oxide-
based nanomagnets have been described as ‘non-invasive’
contrast agents as MR probes, more practical confirma-
tion on the effect of such particles on normal cellular
functionalities have been reported in recent years. There-
fore, the direction of future research should be high-
lighted to elevate the techniques into other areas, such as
nanoarticulation and nanomodulation of cells. The
combination of advanced synthetic technology of nano-
magnets and drug delivery techniques will enable re-
searchers to explore the cellular events under certain
conditions, such as magnetic-vortex-mediated apoptosis
and controlled release of therapeutic agents in a con-
trolled manner.
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